Platelet Modulation: A Study of Angiogenic and Coagulation Proteins in Patients With Cancer



Status:Completed
Conditions:Cancer, Cancer
Therapuetic Areas:Oncology
Healthy:No
Age Range:18 - Any
Updated:4/2/2016
Start Date:June 2010
End Date:August 2013
Contact:Chris E Holmes, MD, PhD
Email:ceholmes@uvm.edu
Phone:802-656-0302

Use our guide to learn which trials are right for you!

Platelet Modulation in the Control of Angiogenesis: A Study of Angiogenic and Coagulation Proteins in Patients With Cancer

Blood samples on persons with cancer will be sampled for angiogenic, metastatic and
coagulation proteins.


Inclusion Criteria:

- Patients with a diagnosis of malignancy

Exclusion Criteria:

- Patients taking aspirin, NSAIDs, warfarin or platelet inhibitor therapy
We found this trial at
1
site
?
mi
from
Burlington, VT
Click here to add this to my saved trials